Kornitzer Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Kornitzer Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-18,305	Closed	-$437K	–	546
2019 Q4	$437K	Sell	18,305 -5,180	-22%	-$143K	0.01%	470
2019 Q3	$630K	Sell	23,485 -2,855	-11%	-$80.1K	0.01%	429
2019 Q2	$715K	Hold	26,340	–	–	0.01%	429
2019 Q1	$914K	Hold	26,340	–	–	0.02%	391
2018 Q4	$514K	Sell	26,340 -976,116	-97%	-$20.1M	0.01%	425
2018 Q3	$26.7M	Sell	1,002,456 -164,265	-14%	-$5.36M	0.42%	87
2018 Q2	$44.1M	Buy	1,166,721 +96,777	+9%	+$3.7M	0.74%	27
2018 Q1	$34.9M	Buy	1,069,944 +243,917	+30%	+$10.7M	0.6%	48
2017 Q4	$40.2M	Buy	826,027 +98,215	+13%	+$4.97M	0.68%	30
2017 Q3	$39.3M	Buy	727,812 +202,925	+39%	+$11.9M	0.69%	32
2017 Q2	$29.5M	Buy	+524,887	New	+$21M	0.52%	62

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Kornitzer Capital Management's PTLA Position: Q1 2020 in Review

Kornitzer Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 18,305 shares — an estimated $437K sold.

Kornitzer Capital Management first reported a position in PTLA in Q2 2017 and held it in 11 quarters. The position peaked at $44.1M in Q2 2018. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Kornitzer Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Kornitzer Capital Management sold 18,305 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $437K.
Kornitzer Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2017 and held it in 11 quarters.
Kornitzer Capital Management's Portola Pharmaceuticals, Inc. position peaked at $44.1M in Q2 2018.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Kornitzer Capital Management's 13F filing for Q1 2020, filed 30 Apr 2020.